People: Sagent Pharmaceuticals Inc (SGNT.O)

SGNT.O on Consolidated Issue listed on NASDAQ Global Market

16.28USD
17 May 2013
Price Change (% chg)

$0.34 (+2.13%)
Prev Close
$15.94
Open
$16.11
Day's High
$16.29
Day's Low
$15.71
Volume
501,007
Avg. Vol
57,894
52-wk High
$19.89
52-wk Low
$12.62

Search Stocks

Behrens, Mary 

Brief Biography

Ms. Mary Taylor Behrens is Independent Director of Sagent Pharmaceuticals Inc., since November 2010. Ms. Behrens has been engaged in private consulting since February 2003 and has held the position of President of Newfane Advisors, Inc., a consulting firm, since November 2004. Prior to that, from February 2001 until January 2003, Ms. Behrens served as Head or Co-Head of Merrill Lynch Investment Managers, Americas Region. From February 1998 until January 2001, Ms. Behrens was a Senior Vice President of Merrill Lynch & Co., serving as Head of Human Resources and a member of its Executive Committee. Ms. Behrens served as a member of the board of directors of Manor Care, Inc. from November 2004 until it went private in December 2007. Ms. Behrens holds a BA in Government from Georgetown University.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Excercisable -- --
Unexercisable -- --
Excercised -- --
Name Fiscal Year Total

Jeffrey Yordon

6,118,340

James Hussey

--

Jonathon Singer

778,685

Michael Logerfo

355,575

Albert Patterson

354,368

Lorin Drake

290,957
As Of 30 Dec 2011
Search Stocks